What is PEGUS Research?
PEGUS Research is a pioneering firm dedicated to innovation and agile solutions in complex research projects. The company has distinguished itself by conceptualizing and implementing the use of pharmacies as enrollment sites and pharmacists as principal investigators for self-selection and actual use studies. This unique approach has enabled PEGUS Research to build an extensive network of trained and experienced pharmacy sites and principal investigators, facilitating robust data collection and clinical studies. Notably, the company spearheaded the first actual use trial in the United Kingdom, supporting the successful Rx-to-OTC switch of a medication, demonstrating its capability in navigating regulatory pathways and market transitions.
How much funding has PEGUS Research raised?
PEGUS Research has raised a total of $977K across 2 funding rounds:
Debt
$350K
Debt
$627K
Debt (2020): $350K with participation from PPP
Debt (2021): $627K led by PPP
What's next for PEGUS Research?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for PEGUS Research. This capital is expected to fuel further expansion of its innovative research methodologies, potentially broadening its network of pharmacy sites and investigator collaborations. The company is well-positioned to leverage this financial backing to enhance its data collection capabilities and pursue new clinical study opportunities, further solidifying its leadership in pharmaceutical research and development. Future endeavors may include scaling its operations to support more complex trials and exploring new therapeutic areas for OTC switch initiatives.
See full PEGUS Research company page
